Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001932582-25-000002
Filing Date
2025-06-10
Accepted
2025-06-10 12:16:51
Documents
1
Effectiveness Date
2025-06-10
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11919
  Complete submission text file 0001932582-25-000002.txt   13069
Mailing Address 25 EAST ERIE STREET CHICAGO IL 60611
Business Address 25 EAST ERIE STREET CHICAGO IL 60611 312-587-3800
Driehaus Life Sciences (QP) Fund, L.P. (Filer) CIK: 0001932582 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-448698 | Film No.: 251036445